A nurse is reviewing a client’s medical history before administering a new prescription for atropine. Which of the following client conditions is contraindicated?

A. Zinc is not known to significantly interfere with the absorption of levothyroxine. While it is important to consider potential interactions with any supplement, zinc does not require a specific time gap when taken with levothyroxine.
B. Vitamin C does not interfere with the absorption of levothyroxine. In fact, some studies suggest that vitamin C might enhance the absorption of levothyroxine, but it does not necessitate a waiting period.
C. Calcium is known to interfere with the absorption of levothyroxine. Calcium supplements can bind to levothyroxine in the gastrointestinal tract, reducing its absorption. Therefore, it is recommended to wait at least 4 hours after taking levothyroxine before consuming calcium supplements.
D. Ginkgo biloba does not have a significant interaction with levothyroxine. While it is always good practice to monitor for any potential interactions, ginkgo biloba does not require a specific waiting period when taken with levothyroxine.

A. Taking a high-ceiling diuretic, such as furosemide, can lead to hypokalemia (low potassium levels), which increases the risk of digoxin toxicity. Low potassium levels enhance the effects of digoxin on the heart, making toxicity more likely.
B. Taking an HMG-CoA reductase inhibitor (statin) is not directly related to digoxin toxicity. Statins are used to lower cholesterol levels and do not significantly interact with digoxin.
C. Having a 10-year history of COPD does not predispose a client to digoxin toxicity. COPD affects the respiratory system and is not directly related to digoxin metabolism or excretion.
D. Having a prolapsed mitral valve is a cardiac condition but does not specifically increase the risk of digoxin toxicity. The primary concern with digoxin toxicity is electrolyte imbalances, particularly potassium levels.